Efficacy and Safety of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1
Neurol 98:e938-e946, Hwang, J.,et al, 2022
Hydrocephalus in Patients with Neurofibromatosis Type 1: MR Imaging Findings and the Outcome of Endoscopic Third Ventriculostomy
AJNR 32:643-46, Dincer, A.,et al, 2011
Transition to Adult Care for Children with Chronic Neurological Disorders
Ann Neurol 69:437-444, Camfiled, P. & Camfield, C., 2011
Clinical and Mutational Spectrum of Neurofibromatosis Type 1-Like Syndrome
JAMA 302:2111-2118, 2150, 2170, Messian,L.,et al, 2009
Optic Pathway Gliomas in Neurofibromatosis-1: Controversies and Recommendations
Ann Neurol 61:189-198, Listernick,R.,et al, 2007
Phaeochromocytoma
Lancet 366:665-675, Lenders,J.W.M.,et al, 2005
Cognitive Function and Academic Performance in Neurofibromatosis 1:North
K. N. , et al, Neurol 48:1121-11277., , 1997
The Management of Brainstem Gliomas in Patients with Neurofibromatosis 1
Neurol 46:1652-1660, Pollack,I.F.,et al, 1996
Brainstem Tumors in Patients with Neurofibromatosis Type 1:A Distinct Clinical Entity
Neurol 45:1897-1902, Molloy,P.T.,et al, 1995
Neurofibromatosis Type 1:The Cognitive Phenotype
J Pediatr 124:S1-S8, Hofman,K.J.,et al, 1994
Specific Learning Disability in Children with Neurofibromatosis Type 1:Significance of MRI Abnormalities
Neurol 44:878-883, North,K.,et al, 1994
Gliomas of the Anterior Visual Pathway
Surv Ophthalmol 38:427-452, Dutton, J., 1994
Occurrence of Both Neurofibromatosis 1 and 2 in the Same Individual with a Rapidly Progressive Course
Neurol 39:282-283, Sadeh,M.,et al, 1989
Neurofibromatosis Type 1 (Recklinghausen's Disease) , Neurologic and Cognitive Assessment
Am J Dis Child 143:833-837, Eldridge,R.,et al, 1989